Ligand Pharmaceuticals Inc
(FRA:LGDN)
€
252
+8 (+3.28%)
Market Cap: 5.22 Bil
Enterprise Value: 4.92 Bil
PE Ratio: 40.11
PB Ratio: 5.94
GF Score: 74/100 Ligand Pharmaceuticals Inc (FRA:LGDN) Transcripts
- 1